New York Life Investment Management LLC Sells 6,478 Shares of Lam Research Corporation $LRCX

New York Life Investment Management LLC decreased its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 3.4% in the 3rd quarter, Holdings Channel reports. The fund owned 185,780 shares of the semiconductor company’s stock after selling 6,478 shares during the period. New York Life Investment Management LLC’s holdings in Lam Research were worth $24,876,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Gilliland Jeter Wealth Management LLC grew its stake in shares of Lam Research by 0.3% during the third quarter. Gilliland Jeter Wealth Management LLC now owns 26,501 shares of the semiconductor company’s stock worth $3,548,000 after buying an additional 69 shares during the last quarter. Gold Investment Management Ltd. grew its position in Lam Research by 0.5% during the 3rd quarter. Gold Investment Management Ltd. now owns 14,736 shares of the semiconductor company’s stock worth $1,973,000 after acquiring an additional 70 shares during the last quarter. Hemington Wealth Management grew its position in Lam Research by 4.3% during the 3rd quarter. Hemington Wealth Management now owns 1,731 shares of the semiconductor company’s stock worth $231,000 after acquiring an additional 72 shares during the last quarter. Magnus Financial Group LLC increased its holdings in Lam Research by 0.3% in the 3rd quarter. Magnus Financial Group LLC now owns 22,838 shares of the semiconductor company’s stock worth $3,058,000 after purchasing an additional 76 shares in the last quarter. Finally, Natural Investments LLC raised its position in Lam Research by 2.4% in the third quarter. Natural Investments LLC now owns 3,408 shares of the semiconductor company’s stock valued at $456,000 after purchasing an additional 79 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Price Performance

Shares of LRCX opened at $231.01 on Monday. The firm has a market cap of $288.48 billion, a PE ratio of 47.34, a price-to-earnings-growth ratio of 2.49 and a beta of 1.78. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $251.87. The business’s 50 day moving average price is $194.38 and its two-hundred day moving average price is $151.05. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the previous year, the business posted $0.91 EPS. Lam Research’s revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is currently 21.31%.

Insider Activity

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.31% of the stock is owned by company insiders.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam announced a strategic alliance with CEA‑Leti and an internal leadership shift aimed at accelerating AI‑equipment development — investors see this as direct exposure to faster AI capex cycles. Lam Research Targets AI Growth With CEA Leti Deal And Leadership Shift
• Positive Sentiment: Celebrity investor/TV host Jim Cramer publicly endorsed adding LRCX to portfolios, raising retail/institutional interest and trading flows. Lam Research (LRCX) Is the Future, Says Jim Cramer
• Positive Sentiment: Argus and other analysts lifted price targets (Argus to $280) and the sell‑side average implies roughly 30% upside — upgrades and higher targets support buying interest. Argus Increases Lam Research Price Target to $280.00
• Positive Sentiment: Lam declared a $0.26 quarterly dividend (0.5% yield) — modest cash return but signals board confidence in cash flow and capital allocation. Lam Research Corporation Declares Quarterly Dividend
• Neutral Sentiment: Zacks and other screens highlight LRCX as a momentum pick amid recent market weakness — this flags participation from quant/momentum funds but also exposes the stock to volatility in a tech selloff. 3 Momentum Anomaly Stocks to Buy as Tech Rout Spooks Markets
• Neutral Sentiment: Company announced a board addition and COO transition — governance/leadership updates that deserve monitoring but aren’t an immediate revenue driver. Lam Research Announces Board Addition and COO Transition
• Negative Sentiment: Shares had a sharp pullback earlier in the week (noted as “down 10% in two days”), reflecting broader tech/crypto volatility — that recent selling created a short-term risk that some traders are buying into. Down 10 In Two Days, Is Lam Research A Good Buy?

Analyst Upgrades and Downgrades

LRCX has been the subject of several recent research reports. JPMorgan Chase & Co. upped their price objective on Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. UBS Group set a $300.00 target price on shares of Lam Research in a report on Thursday, January 29th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $290.00 price target (up previously from $260.00) on shares of Lam Research in a research note on Thursday, January 29th. Morgan Stanley boosted their price objective on shares of Lam Research from $211.00 to $244.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 29th. Finally, Evercore set a $275.00 price objective on Lam Research in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and an average price target of $244.57.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.